CMS Announces First 10 Drugs Subject to Price Negotiation
August 31, 2023
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will
Celebrating 35 years of making Medicare more accessible, affordable, and equitable!
Prescription Drugs
The Inflation Reduction Act (IRA) takes important steps to reduce drug prices and lower costs for people with Medicare and the program, such as capping beneficiary out-of-pocket spending; requiring Medicare to negotiate drug prices; and expanding eligibility for the full Part D low-income subsidy (LIS). We support an implementation process that centers the beneficiary experience and look forward to building upon these landmark policies.
Centers for Medicare & Medicaid Services Announces First 10 Medicare Part D Drugs Subject to Negotiation Under the Inflation Reduction Act (IRA)
August 29, 2023
—Statement by Fred Riccardi, President of the Medicare Rights Center– Washington DC—The Medicare Rights Center applauds a historic milestone achieved
Inflation Reduction Act and Affordable Care Act Working Together to Lower Health Care Costs
August 17, 2023
In advance of this week’s one-year anniversary of the Inflation Reduction Act (IRA), the Biden-Harris administration released a set of
Rising Drug Prices Demonstrate Need for Inflation Reduction Act’s Changes
August 17, 2023
This week marked the one-year anniversary of the signing of the Inflation Reduction Act (IRA), landmark legislation that allows Medicare
Public Supports More Drug Price Regulation, Unaware of Inflation Reduction Act Provisions
August 10, 2023
As we near the first anniversary of the Inflation Reduction Act (IRA), recent public polling by KFF shows that many
HHS Projects Significant Medicare Beneficiary Savings Under the IRA
July 13, 2023
The Inflation Reduction Act (IRA) made key changes to improve prescription drug affordability for people with Medicare. Important reforms that
New Tools to Improve Access to Medicare Part D Financial Assistance
June 15, 2023
For many low-income Medicare beneficiaries, the Part D Low-Income Subsidy (LIS) program (also called “Extra Help”) can be a lifeline,
Merck Sues in Longshot Bid to Derail Medicare Drug Price Negotiation
June 8, 2023
This week, the pharmaceutical giant Merck sued the U.S. Department of Health and Human Services (HHS), challenging Medicare’s authority to
Study Finds Older Adults Skipping Medications Due to Cost
May 25, 2023
A recently released study found that in 2022, over 20% of adults 65 and older experienced cost-related medication nonadherence, meaning
CMS Announces First 10 Drugs Subject to Price Negotiation
August 31, 2023
On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will
Centers for Medicare & Medicaid Services Announces First 10 Medicare Part D Drugs Subject to Negotiation Under the Inflation Reduction Act (IRA)
August 29, 2023
—Statement by Fred Riccardi, President of the Medicare Rights Center– Washington DC—The Medicare Rights Center applauds a historic milestone achieved
Inflation Reduction Act and Affordable Care Act Working Together to Lower Health Care Costs
August 17, 2023
In advance of this week’s one-year anniversary of the Inflation Reduction Act (IRA), the Biden-Harris administration released a set of
Rising Drug Prices Demonstrate Need for Inflation Reduction Act’s Changes
August 17, 2023
This week marked the one-year anniversary of the signing of the Inflation Reduction Act (IRA), landmark legislation that allows Medicare
Public Supports More Drug Price Regulation, Unaware of Inflation Reduction Act Provisions
August 10, 2023
As we near the first anniversary of the Inflation Reduction Act (IRA), recent public polling by KFF shows that many
HHS Projects Significant Medicare Beneficiary Savings Under the IRA
July 13, 2023
The Inflation Reduction Act (IRA) made key changes to improve prescription drug affordability for people with Medicare. Important reforms that
New Tools to Improve Access to Medicare Part D Financial Assistance
June 15, 2023
For many low-income Medicare beneficiaries, the Part D Low-Income Subsidy (LIS) program (also called “Extra Help”) can be a lifeline,
Merck Sues in Longshot Bid to Derail Medicare Drug Price Negotiation
June 8, 2023
This week, the pharmaceutical giant Merck sued the U.S. Department of Health and Human Services (HHS), challenging Medicare’s authority to
Study Finds Older Adults Skipping Medications Due to Cost
May 25, 2023
A recently released study found that in 2022, over 20% of adults 65 and older experienced cost-related medication nonadherence, meaning